Literature DB >> 7035458

Insulin-stimulated phosphorylation of ATP-citrate lyase in isolated hepatocytes. Stoichiometry and relation to the phosphoenzyme intermediate.

M C Alexander, J L Palmer, R H Pointer, E M Kowaloff, L L Koumjian, J Avruch.   

Abstract

We have estimated the insulin-stimulated phosphorylation of ATP-citrate lyase by two methods. Isolated hepatocytes incorporate extracellular 32P into [gamma-35P] ATP and immunoprecipitated ATP-citrate lyase to steady state levels by 1 h. The content of acid-stable 32P in hepatocyte ATP-citrate lyase at steady state is 0.33 +/- 0.038 mol of P/mol (tetrameric) holoenzyme. Insulin (1 milliunit/ml) increases the 32P content of immunoprecipitated lyase 2- to 3-fold in 10 min. Over 90% of acid-stable 32P on lyase is 32P-serine in enzyme isolated from both control and insulin-treated cells. ATP-citrate lyase isolated from hepatocytes contains 0.95 +/- 0.1 mol of alkali-labile phosphate/mol of holoenzyme. Insulin treatment of hepatocytes (1 milliunit/ml for 10 min) increases the alkali-labile P content by 45%. Evidence is presented which indicates that the insulin-stimulated phosphorylation does not arise by intramolecular migration from the catalytic phosphoenzyme intermediate. These observations support the conclusion that insulin-stimulated phosphorylation of ATP-citrate lyase is mediated either by an insulin-induced increase in the activity of lyase kinase and/or decrease in a lyase phosphatase. The functional role of the substoichiometric phosphorylation of ATP-citrate lyase remains unknown.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7035458

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Evidence that insulin activates casein kinase 2 in rat epididymal fat-cells and that this may result in the increased phosphorylation of an acid-soluble 22 kDa protein.

Authors:  T A Diggle; C Schmitz-Peiffer; A C Borthwick; G I Welsh; R M Denton
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

2.  Possible involvement of NADPH requirement in regulation of glucose-6-phosphate and 6-phosphogluconate dehydrogenase levels in rat liver.

Authors:  A Ayala; I Fabregat; A Machado
Journal:  Mol Cell Biochem       Date:  1990-06-25       Impact factor: 3.396

3.  Activation of casein kinase II in response to insulin and to epidermal growth factor.

Authors:  J Sommercorn; J A Mulligan; F J Lozeman; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  ATP-citrate lyase multimerization is required for coenzyme-A substrate binding and catalysis.

Authors:  Gleb A Bazilevsky; Hayley C Affronti; Xuepeng Wei; Sydney L Campbell; Kathryn E Wellen; Ronen Marmorstein
Journal:  J Biol Chem       Date:  2019-03-15       Impact factor: 5.157

5.  The role of NADPH in the regulation of glucose-6-phosphate and 6-phosphogluconate dehydrogenases in rat adipose tissue.

Authors:  A Ayala; I Fabregat; A Machado
Journal:  Mol Cell Biochem       Date:  1991-06-26       Impact factor: 3.396

6.  Characterization and use of monoclonal antibodies for isolation of phosphotyrosyl proteins from retrovirus-transformed cells and growth factor-stimulated cells.

Authors:  A R Frackelton; A H Ross; H N Eisen
Journal:  Mol Cell Biol       Date:  1983-08       Impact factor: 4.272

7.  Insulin and growth factors stimulate the phosphorylation of a Mr-22000 protein in 3T3-L1 adipocytes.

Authors:  P J Blackshear; R A Nemenoff; J Avruch
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

8.  Preliminary characterization of a heat-stable protein from rat adipose tissue whose phosphorylation is stimulated by insulin.

Authors:  P J Blackshear; R A Nemenoff; J Avruch
Journal:  Biochem J       Date:  1982-06-15       Impact factor: 3.857

9.  A lens intercellular junction protein, MP26, is a phosphoprotein.

Authors:  K R Johnson; P D Lampe; K C Hur; C F Louis; R G Johnson
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.